| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 800 | $1,410.12 | $1,128,096.00 | -13.1% | -19.7% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 6,939 | $227.83 | $1,580,926.39 | -4.0% | -9.0% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,334 | $230.77 | $307,844.51 | -0.6% | -9.0% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 3,594 | $231.02 | $830,278.57 | -1.0% | -9.0% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 435 | $230.77 | $100,384.08 | -0.2% | -9.0% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 4,639 | $231.20 | $1,072,537.92 | -0.5% | -9.0% | - | |
| Feb 3, 2026 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 90,024 | $230.72 | $20,770,418.93 | -8.0% | -9.0% | - | |
| Jan 29, 2026 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 5,064 | $235.38 | $1,191,953.30 | -1.6% | -15.9% | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 2,213 | $238.98 | $528,853.09 | -0.8% | -15.2% | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,970 | $238.78 | $1,425,506.11 | -1.4% | -15.2% | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Fesko John | President, Chief Bus. Officer | Sell | 1,712 | $238.98 | $409,127.25 | -0.5% | -15.2% | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 482 | $239.39 | $115,388.13 | - | -15.2% | - | |
| Jan 28, 2026 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 1,886 | $239.01 | $450,773.13 | -0.4% | -15.2% | - | |
| Jan 16, 2026 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 298 | $8.15 | $2,428.49 | -3.6% | - | - | |
| Jan 16, 2026 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 970 | $8.15 | $7,904.82 | -2.4% | - | - | |
| Jan 16, 2026 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 298 | $8.15 | $2,428.49 | -3.4% | - | - | |
| Jan 16, 2026 | BDSX Biodesix Inc | Vazquez Chris65 | Chief Accounting Officer | Sell | 83 | $8.15 | $676.39 | -7.2% | - | - | |
| Jan 16, 2026 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 298 | $8.15 | $2,428.49 | -2.1% | - | - | |
| Jan 15, 2026 | CDNA Caredx, Inc. | Hanna John Walter Jr | President And CEO | Sell | 10,156 | $21.05 | $213,804.11 | -1.6% | -22.0% | - | |
| Jan 13, 2026 | TWST Twist Bioscience Corp | Finn Patrick John72 | President And COO | Sell | 23,279 | $40.00 | $931,160.00 | -6.9% | +19.1% | - | |
| Jan 13, 2026 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 3,000 | $40.00 | $120,000.00 | -2.1% | +19.1% | - | |
| Jan 9, 2026 | TWST Twist Bioscience Corp | Laponis Adam58 | Chief Financial Officer | Sell | 2,738 | $35.26 | $96,544.62 | -1.9% | +38.3% | - | |
| Jan 7, 2026 | GH Guardant Health, Inc. | Monroe Terilyn J.45 | Chief People Officer | Sell | 10,031 | $112.08 | $1,124,279.50 | -13.1% | -15.1% | - | |
| Jan 6, 2026 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,017 | $38.76 | $155,693.56 | -6.2% | -38.3% | - | |
| Jan 2, 2026 | PRPO Precipio, Inc. | Sabet Ahmed Zaki51 | Chief Operating Officer | Buy | 20 | $23.40 | $468.00 | +2.8% | +6.6% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.